US20110184449A1 - Marker delivery device with obturator - Google Patents

Marker delivery device with obturator Download PDF

Info

Publication number
US20110184449A1
US20110184449A1 US13/079,849 US201113079849A US2011184449A1 US 20110184449 A1 US20110184449 A1 US 20110184449A1 US 201113079849 A US201113079849 A US 201113079849A US 2011184449 A1 US2011184449 A1 US 2011184449A1
Authority
US
United States
Prior art keywords
obturator
marker delivery
distal end
marker
substantially sealed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/079,849
Inventor
Paul Lubock
Richard Quick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SenoRx Inc
Original Assignee
SenoRx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SenoRx Inc filed Critical SenoRx Inc
Priority to US13/079,849 priority Critical patent/US20110184449A1/en
Publication of US20110184449A1 publication Critical patent/US20110184449A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3468Trocars; Puncturing needles for implanting or removing devices, e.g. prostheses, implants, seeds, wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3498Valves therefor, e.g. flapper valves, slide valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00796Breast surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/06Measuring instruments not otherwise provided for
    • A61B2090/062Measuring instruments not otherwise provided for penetration depth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3904Markers, e.g. radio-opaque or breast lesions markers specially adapted for marking specified tissue
    • A61B2090/3908Soft tissue, e.g. breast tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3954Markers, e.g. radio-opaque or breast lesions markers magnetic, e.g. NMR or MRI
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3987Applicators for implanting markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/40Apparatus fixed or close to patients specially adapted for providing an aseptic surgical environment

Definitions

  • This invention relates generally to the field of medical devices and methods.
  • the invention relates to devices and methods for marking a biopsy site.
  • tissue samples are often removed from tumors, lesions, organs, muscles and other tissues of the body.
  • removal of tissue samples may be accomplished by open surgical technique (i.e., removal of a small sample of tissue through a small surgical incision using a local anesthetic), or through the use of a specialized biopsy instrument such as a biopsy needle.
  • diagnostic tests or examinations such as a) gross and microscopic examination to determine cytology and/or histology, b) biochemical analyses to determine the presence or absence of chemical substances which indicate certain disease states, c) microbiological culturing to determine the presence of bacteria or other microbes, and/or d) other diagnostic procedures.
  • diagnostic tests or examinations such as a) gross and microscopic examination to determine cytology and/or histology, b) biochemical analyses to determine the presence or absence of chemical substances which indicate certain disease states, c) microbiological culturing to determine the presence of bacteria or other microbes, and/or d) other diagnostic procedures.
  • an obturator When performing an image guided biopsy procedure an obturator is used as a place holder and is placed in tissue such that its tip will be located at the point in the patient's body where the biopsy is to be taken or where a biopsy site marker or tissue marker is to be placed after a biopsy procedure. Subsequent images are acquired that can confirm the correct placement of the obturator.
  • the obturator When the obturator is placed at the desired location within the body, blood can enter the lumen of the obturator prior to delivery of the tissue markers. This backflow of blood into the obturator creates a risk of blood clotting.
  • obturators are constructed of homogeneous materials.
  • the tip of the obturator is located by indexing through many cross sectional views (typically every 2 mm, but higher and lower discriminations are possible).
  • the material of the obturator will be distinguishable in the cross sectional images to a varying degree depending on the morphology of the tissue and the obturator's own material makeup. Since the obturator is homogeneous, the signature of the obturator will not vary from one cross-sectional image to the next along its length.
  • the tip of the obturator is located by selecting the first cross-sectional image in which the obturator is not seen. This result can be visually ambiguous depending on the relative strength of the image signature of the obturator compared to the surrounding tissue.
  • the biopsy sample After the biopsy sample is taken, it may take several days or weeks before the results of the examination of the sample are obtained, and still longer before an appropriate treatment decision is reached. If the decision involves surgery it is clearly important for the surgeon to find the location in the breast from where the tumor tissue has been taken in the biopsy procedure, so that the entire tumor and possibly surrounding healthy tissue can be removed.
  • radiographically imageable tissue features originally detected in a mammogram, may be removed, altered or obscured by the biopsy procedure.
  • tissue features originally detected in a mammogram
  • the present invention provides a marker delivery device and method for placing an obturator at the desired site in a patient's body as a placeholder and for delivering such markers into the biopsy cavity.
  • This invention relates to devices and methods for placement of an intracorporeal object that functions as a marker, a therapeutic agent or a diagnostic agent and particularly for placing an obturator at a desired location within a patient's body and for delivering one or more intracorporeal objects through the obturator to that location.
  • the obturator may operate as a place-holder during an image guided procedure such as a biopsy. The distal end of the obturator is placed where the procedure is to be performed or one or more intracorporeal objects or bodies are to be delivered.
  • the device includes an obturator which has an elongated shaft with a internal lumen, a proximal end, and a substantially sealed distal end which prevents or minimizes the backflow of body fluids, such as blood, though the lumen of the obturator.
  • the substantially sealed distal end can be a penetrable membrane or may have petals or a duckbill-type valve which are configured to allow passage of one or more intracorporeal objects or a delivery tube with one or more intracorporeal objects therethrough while preventing or minimizing entry of body fluids into the inner lumen of the obturator.
  • the obturator is configured to fit within a procedure cannula, e.g. a cannula of a biopsy device, for example, the cannula of SenoRx's EnCorTM Magnetic Resonance Imaging Breast Biopsy System.
  • the cannula provides access to the desired location within the patient's body.
  • the delivery tube has a delivery lumen configured to contain one or more intracorporeal objects.
  • the distal tip is configured to penetrate the substantially sealed distal end of the obturator so that the intracorporeal bodies can be delivered while the obturator is in place within the body.
  • the shape of the distal tip may be sharp or needle like when the sealed distal end of the obturator has a membrane or it may be blunt or rounded when the distal end of the obturator is petalled or has a one-way valve.
  • the device preferably further includes a plunger having an elongated shaft with a proximal portion and a distal portion.
  • the plunger is configured to be slidably disposed within the lumen of the delivery tube and is located proximal to the one or more intracorporeal objects within the lumen thereof.
  • the distal end thereof moves one or more intracorporeal objects toward and eventually through the distal end of the delivery tube.
  • the plunger preferably has an enlarged proximal end to prevent the distal portion of the plunger from advancing too far within the delivery lumen.
  • a fluid may be used to advance the intracorporeal objects through the opening.
  • a method for delivering one or more intracorporeal objects to a site within a patient's body includes providing the above described device.
  • the obturator is placed at a desired location within a patient's body.
  • the delivery tube is advanced distally within the obturator until the distal tip passes through the substantially sealed distal end of the obturator.
  • the plunger is advanced distally within the delivery tube so that at least one intracorporeal object is pushed though the opening of the distal tip.
  • the distal portion of the obturator includes a detectable element capable of producing a significant image signature at the location in the patient's body where the distal portion of the obturator is placed.
  • this embodiment includes an obturator having an elongated shaft, a proximal end, a substantially sealed distal end, and a detectable element, preferably in the form of a ring at or near the distal end.
  • a detectable element capable of producing a significant image signature is located adjacent to the substantially sealed distal end, preferably in the form of ring at the junction between the distal tip and the elongated shaft.
  • the invention in one form thereof, is directed to a marker delivery device.
  • the marker delivery device includes an obturator having an elongated shaft, an internal lumen, a proximal end, and a substantially sealed distal end.
  • the substantially sealed distal end is formed of a penetrable membrane.
  • a marker delivery tube is configured to be slidably disposed within the internal lumen of the obturator.
  • the marker delivery tube has a marker delivery lumen, a proximal end, and a distal tip.
  • the marker delivery lumen is configured to contain one or more tissue markers.
  • the distal tip is configured to puncture the penetrable membrane of the substantially sealed distal end of the obturator to form a passage through which the distal tip extends to facilitate delivery of the one or more tissue markers.
  • the invention in another form thereof, is directed to a marker delivery device.
  • the marker delivery device includes an obturator having an elongated shaft, an internal lumen, a proximal end, and a rounded distal end formed of a penetrable membrane.
  • a marker delivery tube is configured to be slidably disposed within the internal lumen of the obturator.
  • the marker delivery tube has a marker delivery lumen, a proximal end, and a distal tip.
  • the marker delivery lumen is configured to contain one or more tissue markers.
  • the distal tip is configured to puncture the penetrable membrane of the rounded distal end of the obturator to form a passage through which the distal tip extends for delivery of the one or more tissue markers.
  • the invention in another form thereof, is directed to a method for delivering a tissue marker to a site within a body of a patient.
  • the method includes providing an obturator having an elongated shaft, an internal lumen, a proximal end and a substantially sealed distal end, the substantially sealed distal end being formed of a penetrable membrane; providing a marker delivery tube containing one or more tissue markers, the marker delivery tube having a distal tip; slidably disposing the marker delivery tube within the internal lumen of the obturator; advancing the marker delivery tube within the internal lumen of the obturator toward the penetrable membrane of the substantially sealed distal end of the obturator; and puncturing the penetrable membrane of the substantially sealed distal end of the obturator with the distal tip of the marker delivery tube to form a passage through which the distal tip extends to facilitate delivery of the one or more tissue markers to the site.
  • the devices, systems, and methods of the present invention offer improved delivery by minimizing the backflow of body fluids, such as blood, though the obturator lumen and thereby decreasing a risk of clot formation in the obturator.
  • FIG. 1A is an elevational view of an assembly having features of the invention including a marker delivery shaft and an obturator.
  • FIG. 1B is a transverse cross sectional view of the obturator of FIG. 1A taken along line 1 B- 1 B.
  • FIG. 1C is a transverse cross sectional view of the marker delivery shaft of FIG. 1A taken along lines 1 C- 1 C.
  • FIGS. 2A and 2B are elevational views of a delivery device embodying features of the invention wherein the distal tip of the marker delivery shaft is proximal to the substantially sealed distal end.
  • FIG. 2B is rotated 90° with respect to FIG. 2A .
  • FIG. 2C is a longitudinal cross sectional view taken along lines 2 C- 2 C in FIG. 2A .
  • FIG. 2D is a transverse cross sectional view taken along lines 2 D- 2 D in FIG. 2A .
  • FIG. 3 is a perspective view of a substantially sealed distal end of an obturator having one or more petals.
  • FIG. 4 is a perspective view of a substantially sealed distal end of an obturator having a duck billed valve.
  • FIG. 5 is an elevational view of a distal tip of a marker delivery tubular shaft having a needle-like shape.
  • FIG. 6 is an elevational view of a distal tip of a marker delivery tubular shaft having a blunt end.
  • FIGS. 7A and 7B are elevational views of a distal portion of an obturator embodying features of the invention wherein the distal tip of the marker delivery shaft has partially punctured the substantially sealed distal end of the obturator and the plunger is not yet deployed.
  • FIG. 7B is rotated 90° with respect to FIG. 7A .
  • FIG. 7C is a longitudinal cross sectional view taken along line 7 C- 7 C in FIG. 7A .
  • FIGS. 8A and 8B are elevational views of a distal portion of an obturator embodying features of the invention wherein the distal tip of the marker delivery shaft has completely punctured the substantially sealed distal end of the obturator and the plunger is not yet deployed.
  • FIG. 8B is rotated 90° with respect to FIG. 8A .
  • FIG. 8C is a longitudinal cross sectional view taken along lines 8 C- 8 C in FIG. 8A .
  • FIGS. 9A and 9B are elevational views of a distal portion of an obturator embodying features of the invention wherein the distal tip of the marker delivery shaft has completely punctured the substantially sealed distal end of the obturator and the plunger is deployed.
  • FIG. 9B is rotated 90° with respect to FIG. 9A .
  • FIG. 9C is a longitudinal cross sectional view taken along line 9 C- 9 C in FIG. 9A .
  • FIG. 10A is an elevational view of an obturator embodying features of the invention including a detectable element.
  • FIG. 10B is a cross-sectional view of the obturator shown in FIG. 10A taken along line 10 B- 10 B.
  • FIG. 10C is an enlarged view of Section 10 C in FIG. 10A .
  • FIG. 10D is a longitudinal cross sectional view of the distal end of the obturator taken along line 10 D- 10 D in FIG. 10C .
  • FIG. 10E is an enlarged view of section 10 E shown in FIG. 10D .
  • FIG. 10F is a perspective view of the obturator wherein the distal end of the obturator, the detectable element, and the proximal portion of the obturator are shown separated.
  • FIG. 10G is an enlarged view of Section 10 G shown in FIG. 10F .
  • FIG. 11A is an elevational view of an obturator embodying features of the invention including a plurality of detectable elements or bodies within the obturator.
  • FIG. 11B is a longitudinal cross-sectional view of the obturator shown in FIG. 11A taken along line 11 B- 11 B.
  • FIG. 11C is a longitudinal cross-sectional view of the obturator as in FIG. 11B with the plunger distally advanced to discharge the detectable elements or bodies within the obturator.
  • FIGS. 1A-2D shows an embodiment of a marker delivery device 10 having features of the invention including an obturator 12 and a marker delivery tubular shaft 14 .
  • the obturator 12 has an elongated shaft 16 , an internal lumen 18 , a proximal end 20 and a substantially sealed distal end 22 .
  • the obturator 12 is configured to fit within a cannula 24 of a biopsy device, such as SenoRx's EnCorTM Magnetic Resonance Imaging (MRI) Breast Biopsy System.
  • the cannula 24 provides access to the desired location within a patient's body.
  • the cannula 24 includes depth markings 26 which indicate the distance which the obturator 12 has advanced within the patient's body.
  • the substantially sealed distal end 22 of the obturator 12 is configured to prevent or minimize the backflow of fluids, such as body fluids, through the internal lumen 18 of the obturator 12 .
  • the substantially sealed distal end 22 is formed of a penetrable membrane 28 .
  • the substantially sealed distal end 22 of the obturator 12 has a rounded external surface and is formed of the penetrable membrane 28 .
  • substantially sealed distal end 22 is formed of two or more petals 30 ( FIG. 3 ) or can be formed of a duck-billed valve 32 ( FIG. 4 ).
  • the marker delivery tubular shaft 14 is configured to be slidably disposed within the internal lumen 18 of the obturator 12 .
  • the tubular shaft 16 has a marker delivery lumen 34 configured to contain one or more tissue markers 36 for marking a biopsy site, a proximal end 38 , and a distal tip 40 with an opening 42 for passage of one or more of the markers 36 .
  • the tissue markers 36 may be those described in U.S. Pat. No. 6,996,433, U.S. Pat. No. 6,993,375, U.S. Pat. No. 6,862,470, U.S. Pat. No. 6,725,083, U.S. Pat. No. 6,662,041, U.S. Pat. No. 6,567,689, U.S. Pat.
  • the marker delivery tubular shaft 14 preferably also includes depth markings 44 which indicate the distance which the tubular shaft 14 has advanced within the obturator 12 .
  • the distal tip 40 of the marker delivery shaft 14 is configured to penetrate the substantially sealed distal end 22 of the obturator 12 so that tissue markers 36 can be delivered while the obturator 12 is in place within the patient's body.
  • the distal tip 40 is needle shaped 46 ( FIG. 5 ), however, the distal tip can alternatively be a blunt tip 48 ( FIG. 6 ) which is capable of penetrating a substantially sealed distal end 22 that is formed of a penetrable membrane 28 which is weakened or a distal end 22 with petals 30 or a valve 32 .
  • the marker delivery device 10 also includes a plunger 50 having an elongated shaft 52 with a distal end 54 and a proximal end 56 .
  • the plunger 50 is configured to be slidably disposed within the marker delivery lumen 34 and is located proximal to the one or more tissue markers 36 within the marker delivery lumen 34 .
  • the plunger 50 When the plunger 50 is extended distally within the marker delivery lumen 34 it moves one or more tissue markers toward and eventually through the opening 42 in the distal tip 40 of the marker delivery shaft 14 .
  • the plunger 50 preferably has an enlarged proximal end 58 to prevent its entry into the lumen 34 .
  • a fluid (not shown) may be used to advance the markers 36 through the opening 42 in the distal tip 40 of the marker delivery tubular shaft 14 .
  • FIGS. 7A-7C show the distal tip 40 of the marker delivery tube 14 partially penetrating the substantially sealed distal end 22 of the obturator 12 .
  • the distal tip 40 of the marker delivery tube 14 has partially punctured the penetrable membrane 28 of the substantially sealed distal end 22 of the obturator 12 , and the plunger 50 is not yet deployed.
  • the tissue markers 36 in FIG. 7A-7C are contained within the marker delivery lumen 34 .
  • FIGS. 8A-8C show the distal tip 40 completely penetrating the substantially sealed distal end 22 of the obturator 12 and the tissue markers 36 within the marker delivery lumen 34 .
  • the distal tip 40 of the marker delivery tube 14 has completely punctured the penetrable membrane 28 of the substantially sealed distal end 22 of the obturator 12 , and the plunger 50 is not yet deployed.
  • FIGS. 9A-9C show the distal tip 40 of the marker delivery tubular shaft 14 completely penetrating the substantially sealed distal end 22 .
  • the distal tip 40 of the marker delivery tube 14 has completely punctured the penetrable membrane 28 of the substantially sealed distal end 22 of the obturator 12 .
  • the plunger 50 is deployed distally within the marker delivery lumen 34 .
  • the obturator 12 has a hub 60 at the proximal end 20 of the obturator shaft 16 .
  • the hub 60 may have gripping ridges 62 which allow a person operating the device 10 to maintain a grip on the device 10 .
  • the marker delivery tubular shaft 14 preferably also has a hub 64 at the proximal end of the marker delivery shaft 38 with gripping ridges 66 . At least a portion of the hub 64 of the marker delivery tubular shaft 14 is configured to fit within the hub 64 of the obturator 12 when the marker delivery shaft 14 is inserted into the obturator 12 .
  • the marker delivery device 10 is preferably formed of a non-magnetic material.
  • a plastic such as MAKROLON®, a polycarbonate from Bayer Material Sciences a division of Bayer AG, is suitable and will not interfere with a magnetic resonance imaging device (MRI).
  • the device may also include a radiopaque material which allows for detection of the device.
  • the location of the obturator 12 may be determined by detecting air within the elongated shaft 16 of the obturator 12 with a magnetic resonance imaging device (not shown).
  • a method for delivering a tissue marker to a site within a patient's body includes providing the above described device.
  • the obturator 12 of the device 10 is inserted into a desired location within a patient's body.
  • the obturator 12 is placed within the cannula 24 of a biopsy device that remains in the patient's body after the biopsy device is removed.
  • the marker delivery tubular shaft 14 is then inserted into the obturator 12 and the distal tip 40 of the tubular shaft 14 is advanced through the substantially sealed distal end 22 of the obturator 12 .
  • At least one tissue marker 36 within the marker delivery tubular shaft 14 is then advanced distally through the opening 42 in the distal tip 40 of the marker delivery tubular shaft 14 .
  • a plunger 50 is advanced distally within the tubular shaft 14 so that at least one tissue marker 36 is moved through the opening 42 in the distal tip 40 .
  • a fluid (not shown) can be used in place of the plunger to move the tissue markers 36 through the distal tip 40 .
  • FIGS. 10A-10G An embodiment of the device having features of the invention, which is shown in FIGS. 10A-10G , includes an obturator 68 having an elongated shaft 70 including a cylindrical wall with an internal lumen 72 , a proximal end 74 , a substantially sealed distal end 76 , and a detectable element 78 capable of producing a relatively significant image signature.
  • the detectable element 78 is incorporated into the obturator 68 at a location determined to be optimum for complimenting the subsequent procedure.
  • the detectable element 78 preferably is in the form of a ring 80 located near the substantially sealed distal end 76 of the obturator 68 .
  • the substantially sealed distal end 76 of the obturator 68 is located on an obturator tip 82 .
  • the detectable element 78 / 80 is in contact with the mating surfaces of a terminal distal end of the cylindrical wall of the elongated shaft 70 and the obturator tip 82 .
  • the cylindrical wall of the elongated shaft 70 also includes at least one aperture 84 and the obturator tip 82 of the obturator 68 preferably includes a raised tab 86 which extends into the aperture 84 to hold the obturator tip 82 in place.
  • the detectable element 78 in ring form 80 may be placed at the point where the obturator tip 82 and the elongated shaft 70 of the obturator 68 meet, i.e., at the junction between the obturator tip 82 and the terminal distal end of the cylindrical wall of the elongated shaft 70 of the obturator 68 .
  • the detectable element 78 is in a form which allows the internal lumen of the obturator 72 to remain unobstructed, such as a ring 80 .
  • the detectable element 78 can also be a small sphere or rod, one or more wires, or a collar. Also any plan-form shape constructed of sheet material, either planar or formed into a non-planar shape.
  • the detectable element 78 may be the entire tip 82 of the obturator 68 .
  • more than one detectable element 78 could be incorporated into the obturator 68 to be used as a marker capable of determining the depth of the obturator 68 within a patient's body (not shown).
  • FIGS. 11A-C illustrate an alternative embodiment of an object delivery device 90 having features of the invention including an obturator 92 which has an elongated shaft 94 , an internal lumen 96 , a proximal end 98 and a substantially sealed distal end 100 .
  • the obturator 92 is configured to fit within a cannula of a biopsy device, such as SenoRx's EnCorTM Magnetic Resonance Imaging (MRI) Breast Biopsy System.
  • the substantially sealed distal end 100 of the obturator 92 is configured to prevent or minimize the backflow of fluids, such as body fluids, through the inner lumen 96 .
  • a plurality of intracorporeal objects 102 e.g. biopsy site markers, is disposed within the inner lumen 96 .
  • a plunger 104 with an enlarged head 106 is slidably disposed in part within the inner lumen 96 proximal to the plurality of intracorporeal objects 102 . Distal movement of the plunger 104 pushes the objects 102 through the distal end into a body site.
  • the intracorporeal objects may not be able to penetrate a membrane, so the substantially sealed distal end 100 may be formed of two or more petals such as shown in FIG. 3 or can be formed of a duck-billed valve such as shown in FIG. 4 .
  • Suitable materials for use as the detectable element 78 are metal, ceramic, metal filled plastic, mineral filled plastic, or a radiopaque material.
  • Radiopaque materials such as stainless steel, platinum, gold, iridium, tantalum, tungsten, silver, rhodium, nickel, bismuth or other radiopaque metals, mixtures of radiopaque metals, oxides of radiopaque metals, barium salts, iodine salts, iodinated materials, and combinations thereof are suitable as well.
  • MRI contrast agents such as Gadolinium and vitamin E may also be employed.
  • an imageable stylet may be used within the inner lumen of the sealed obturator to show the axis of the instrument and the depth of the insertion within the body.
  • the stylet is formed of material which is compatible with MRI and which is seen in MRI generated images. Suitable materials include non-magnetic metals, non-magnetic metal filled plastics, hollow tubes filled at least in part with an MRI visible substance such as Gadolinium or other fluids.

Abstract

A marker delivery device includes an obturator having an elongated shaft, an internal lumen, a proximal end, and a substantially sealed distal end. The substantially sealed distal end is formed of a penetrable membrane. A marker delivery tube is configured to be slidably disposed within the internal lumen of the obturator. The marker delivery tube has a marker delivery lumen, a proximal end, and a distal tip. The marker delivery lumen is configured to contain one or more tissue markers. The distal tip is configured to puncture the penetrable membrane of the substantially sealed distal end of the obturator to form a passage through which the distal tip extends to facilitate delivery of the one or more tissue markers.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is continuation of U.S. patent application Ser. No. 11/499,466, filed Aug. 4, 2006, entitled, “MARKER DELIVERY SYSTEM WITH OBTURATOR”.
  • FIELD OF THE INVENTION
  • This invention relates generally to the field of medical devices and methods. In particular, the invention relates to devices and methods for marking a biopsy site.
  • BACKGROUND OF THE INVENTION
  • In modern medical practice small tissue samples, known as biopsy specimens, are often removed from tumors, lesions, organs, muscles and other tissues of the body. Such removal of tissue samples may be accomplished by open surgical technique (i.e., removal of a small sample of tissue through a small surgical incision using a local anesthetic), or through the use of a specialized biopsy instrument such as a biopsy needle. After the tissue samples have been removed, they are typically subjected to diagnostic tests or examinations such as a) gross and microscopic examination to determine cytology and/or histology, b) biochemical analyses to determine the presence or absence of chemical substances which indicate certain disease states, c) microbiological culturing to determine the presence of bacteria or other microbes, and/or d) other diagnostic procedures. The information obtained from these diagnostic tests and/or examinations can then be used to make or confirm diagnoses and/or to formulate treatment plans for the patient.
  • When performing an image guided biopsy procedure an obturator is used as a place holder and is placed in tissue such that its tip will be located at the point in the patient's body where the biopsy is to be taken or where a biopsy site marker or tissue marker is to be placed after a biopsy procedure. Subsequent images are acquired that can confirm the correct placement of the obturator. When the obturator is placed at the desired location within the body, blood can enter the lumen of the obturator prior to delivery of the tissue markers. This backflow of blood into the obturator creates a risk of blood clotting.
  • Current obturators are constructed of homogeneous materials. During magnetic resonance imaging (MRI) guided biopsies, the tip of the obturator is located by indexing through many cross sectional views (typically every 2 mm, but higher and lower discriminations are possible). The material of the obturator will be distinguishable in the cross sectional images to a varying degree depending on the morphology of the tissue and the obturator's own material makeup. Since the obturator is homogeneous, the signature of the obturator will not vary from one cross-sectional image to the next along its length. The tip of the obturator is located by selecting the first cross-sectional image in which the obturator is not seen. This result can be visually ambiguous depending on the relative strength of the image signature of the obturator compared to the surrounding tissue.
  • After the biopsy sample is taken, it may take several days or weeks before the results of the examination of the sample are obtained, and still longer before an appropriate treatment decision is reached. If the decision involves surgery it is clearly important for the surgeon to find the location in the breast from where the tumor tissue has been taken in the biopsy procedure, so that the entire tumor and possibly surrounding healthy tissue can be removed.
  • However, radiographically imageable tissue features, originally detected in a mammogram, may be removed, altered or obscured by the biopsy procedure. In order for the surgeon or radiation oncologist to direct surgical or radiation treatment to the precise location of the breast lesion several days or weeks after the biopsy procedure was performed, it is desirable that one or more biopsy site markers be placed in or on the patient's body to serve as a landmark for subsequent location of the lesion. The purpose of such markers is to facilitate the surgical procedure that is performed while the marker is detectable.
  • The present invention provides a marker delivery device and method for placing an obturator at the desired site in a patient's body as a placeholder and for delivering such markers into the biopsy cavity.
  • SUMMARY OF THE INVENTION
  • This invention relates to devices and methods for placement of an intracorporeal object that functions as a marker, a therapeutic agent or a diagnostic agent and particularly for placing an obturator at a desired location within a patient's body and for delivering one or more intracorporeal objects through the obturator to that location. The obturator may operate as a place-holder during an image guided procedure such as a biopsy. The distal end of the obturator is placed where the procedure is to be performed or one or more intracorporeal objects or bodies are to be delivered.
  • In one embodiment having features of the present invention the device includes an obturator which has an elongated shaft with a internal lumen, a proximal end, and a substantially sealed distal end which prevents or minimizes the backflow of body fluids, such as blood, though the lumen of the obturator. The substantially sealed distal end can be a penetrable membrane or may have petals or a duckbill-type valve which are configured to allow passage of one or more intracorporeal objects or a delivery tube with one or more intracorporeal objects therethrough while preventing or minimizing entry of body fluids into the inner lumen of the obturator. Preferably the obturator is configured to fit within a procedure cannula, e.g. a cannula of a biopsy device, for example, the cannula of SenoRx's EnCor™ Magnetic Resonance Imaging Breast Biopsy System. The cannula provides access to the desired location within the patient's body.
  • The delivery tube has a delivery lumen configured to contain one or more intracorporeal objects. The distal tip is configured to penetrate the substantially sealed distal end of the obturator so that the intracorporeal bodies can be delivered while the obturator is in place within the body. The shape of the distal tip may be sharp or needle like when the sealed distal end of the obturator has a membrane or it may be blunt or rounded when the distal end of the obturator is petalled or has a one-way valve.
  • The device preferably further includes a plunger having an elongated shaft with a proximal portion and a distal portion. The plunger is configured to be slidably disposed within the lumen of the delivery tube and is located proximal to the one or more intracorporeal objects within the lumen thereof. When the plunger is extended distally within the lumen, the distal end thereof moves one or more intracorporeal objects toward and eventually through the distal end of the delivery tube. The plunger preferably has an enlarged proximal end to prevent the distal portion of the plunger from advancing too far within the delivery lumen. Alternatively, a fluid may be used to advance the intracorporeal objects through the opening.
  • A method for delivering one or more intracorporeal objects to a site within a patient's body includes providing the above described device. The obturator is placed at a desired location within a patient's body. The delivery tube is advanced distally within the obturator until the distal tip passes through the substantially sealed distal end of the obturator. Next the plunger is advanced distally within the delivery tube so that at least one intracorporeal object is pushed though the opening of the distal tip.
  • In one embodiment of the device the distal portion of the obturator includes a detectable element capable of producing a significant image signature at the location in the patient's body where the distal portion of the obturator is placed. Preferably this embodiment includes an obturator having an elongated shaft, a proximal end, a substantially sealed distal end, and a detectable element, preferably in the form of a ring at or near the distal end. A detectable element capable of producing a significant image signature is located adjacent to the substantially sealed distal end, preferably in the form of ring at the junction between the distal tip and the elongated shaft.
  • The invention, in one form thereof, is directed to a marker delivery device. The marker delivery device includes an obturator having an elongated shaft, an internal lumen, a proximal end, and a substantially sealed distal end. The substantially sealed distal end is formed of a penetrable membrane. A marker delivery tube is configured to be slidably disposed within the internal lumen of the obturator. The marker delivery tube has a marker delivery lumen, a proximal end, and a distal tip. The marker delivery lumen is configured to contain one or more tissue markers. The distal tip is configured to puncture the penetrable membrane of the substantially sealed distal end of the obturator to form a passage through which the distal tip extends to facilitate delivery of the one or more tissue markers.
  • The invention, in another form thereof, is directed to a marker delivery device. The marker delivery device includes an obturator having an elongated shaft, an internal lumen, a proximal end, and a rounded distal end formed of a penetrable membrane. A marker delivery tube is configured to be slidably disposed within the internal lumen of the obturator. The marker delivery tube has a marker delivery lumen, a proximal end, and a distal tip. The marker delivery lumen is configured to contain one or more tissue markers. The distal tip is configured to puncture the penetrable membrane of the rounded distal end of the obturator to form a passage through which the distal tip extends for delivery of the one or more tissue markers.
  • The invention, in another form thereof, is directed to a method for delivering a tissue marker to a site within a body of a patient. The method includes providing an obturator having an elongated shaft, an internal lumen, a proximal end and a substantially sealed distal end, the substantially sealed distal end being formed of a penetrable membrane; providing a marker delivery tube containing one or more tissue markers, the marker delivery tube having a distal tip; slidably disposing the marker delivery tube within the internal lumen of the obturator; advancing the marker delivery tube within the internal lumen of the obturator toward the penetrable membrane of the substantially sealed distal end of the obturator; and puncturing the penetrable membrane of the substantially sealed distal end of the obturator with the distal tip of the marker delivery tube to form a passage through which the distal tip extends to facilitate delivery of the one or more tissue markers to the site.
  • The devices, systems, and methods of the present invention offer improved delivery by minimizing the backflow of body fluids, such as blood, though the obturator lumen and thereby decreasing a risk of clot formation in the obturator. These and other advantages of the invention will become more apparent from the following detailed description when taken in conjunction with the accompanying drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1A is an elevational view of an assembly having features of the invention including a marker delivery shaft and an obturator.
  • FIG. 1B is a transverse cross sectional view of the obturator of FIG. 1A taken along line 1B-1B.
  • FIG. 1C is a transverse cross sectional view of the marker delivery shaft of FIG. 1A taken along lines 1C-1C.
  • FIGS. 2A and 2B are elevational views of a delivery device embodying features of the invention wherein the distal tip of the marker delivery shaft is proximal to the substantially sealed distal end. FIG. 2B is rotated 90° with respect to FIG. 2A.
  • FIG. 2C is a longitudinal cross sectional view taken along lines 2C-2C in FIG. 2A.
  • FIG. 2D is a transverse cross sectional view taken along lines 2D-2D in FIG. 2A.
  • FIG. 3 is a perspective view of a substantially sealed distal end of an obturator having one or more petals.
  • FIG. 4 is a perspective view of a substantially sealed distal end of an obturator having a duck billed valve.
  • FIG. 5 is an elevational view of a distal tip of a marker delivery tubular shaft having a needle-like shape.
  • FIG. 6 is an elevational view of a distal tip of a marker delivery tubular shaft having a blunt end.
  • FIGS. 7A and 7B are elevational views of a distal portion of an obturator embodying features of the invention wherein the distal tip of the marker delivery shaft has partially punctured the substantially sealed distal end of the obturator and the plunger is not yet deployed. FIG. 7B is rotated 90° with respect to FIG. 7A.
  • FIG. 7C is a longitudinal cross sectional view taken along line 7C-7C in FIG. 7A.
  • FIGS. 8A and 8B are elevational views of a distal portion of an obturator embodying features of the invention wherein the distal tip of the marker delivery shaft has completely punctured the substantially sealed distal end of the obturator and the plunger is not yet deployed. FIG. 8B is rotated 90° with respect to FIG. 8A.
  • FIG. 8C is a longitudinal cross sectional view taken along lines 8C-8C in FIG. 8A.
  • FIGS. 9A and 9B are elevational views of a distal portion of an obturator embodying features of the invention wherein the distal tip of the marker delivery shaft has completely punctured the substantially sealed distal end of the obturator and the plunger is deployed. FIG. 9B is rotated 90° with respect to FIG. 9A.
  • FIG. 9C is a longitudinal cross sectional view taken along line 9C-9C in FIG. 9A.
  • FIG. 10A is an elevational view of an obturator embodying features of the invention including a detectable element.
  • FIG. 10B is a cross-sectional view of the obturator shown in FIG. 10A taken along line 10B-10B.
  • FIG. 10C is an enlarged view of Section 10C in FIG. 10A.
  • FIG. 10D is a longitudinal cross sectional view of the distal end of the obturator taken along line 10D-10D in FIG. 10C.
  • FIG. 10E is an enlarged view of section 10E shown in FIG. 10D.
  • FIG. 10F is a perspective view of the obturator wherein the distal end of the obturator, the detectable element, and the proximal portion of the obturator are shown separated.
  • FIG. 10G is an enlarged view of Section 10G shown in FIG. 10F.
  • FIG. 11A is an elevational view of an obturator embodying features of the invention including a plurality of detectable elements or bodies within the obturator.
  • FIG. 11B is a longitudinal cross-sectional view of the obturator shown in FIG. 11A taken along line 11B-11B.
  • FIG. 11C is a longitudinal cross-sectional view of the obturator as in FIG. 11B with the plunger distally advanced to discharge the detectable elements or bodies within the obturator.
  • DETAILED DESCRIPTION OF THE INVENTION
  • FIGS. 1A-2D shows an embodiment of a marker delivery device 10 having features of the invention including an obturator 12 and a marker delivery tubular shaft 14. The obturator 12 has an elongated shaft 16, an internal lumen 18, a proximal end 20 and a substantially sealed distal end 22. Preferably, as shown in FIGS. 2A-2D, the obturator 12 is configured to fit within a cannula 24 of a biopsy device, such as SenoRx's EnCor™ Magnetic Resonance Imaging (MRI) Breast Biopsy System. The cannula 24 provides access to the desired location within a patient's body. In some embodiments the cannula 24 includes depth markings 26 which indicate the distance which the obturator 12 has advanced within the patient's body.
  • The substantially sealed distal end 22 of the obturator 12 is configured to prevent or minimize the backflow of fluids, such as body fluids, through the internal lumen 18 of the obturator 12. Preferably the substantially sealed distal end 22 is formed of a penetrable membrane 28. As shown in FIGS. 1A, 2A, 2B and 2C, the substantially sealed distal end 22 of the obturator 12 has a rounded external surface and is formed of the penetrable membrane 28.
  • Alternatively the substantially sealed distal end 22 is formed of two or more petals 30 (FIG. 3) or can be formed of a duck-billed valve 32 (FIG. 4).
  • The marker delivery tubular shaft 14 is configured to be slidably disposed within the internal lumen 18 of the obturator 12. The tubular shaft 16 has a marker delivery lumen 34 configured to contain one or more tissue markers 36 for marking a biopsy site, a proximal end 38, and a distal tip 40 with an opening 42 for passage of one or more of the markers 36. The tissue markers 36 may be those described in U.S. Pat. No. 6,996,433, U.S. Pat. No. 6,993,375, U.S. Pat. No. 6,862,470, U.S. Pat. No. 6,725,083, U.S. Pat. No. 6,662,041, U.S. Pat. No. 6,567,689, U.S. Pat. Nos. 6,427,081, 6,347,241, U.S. Pat. No. 6,161,034, U.S. patent application Ser. No. 10/444,770, U.S. patent application Ser. No. 10/444,428, and U.S. patent application Ser. No. 10/001,043, which are hereby incorporated by reference. The marker delivery tubular shaft 14 preferably also includes depth markings 44 which indicate the distance which the tubular shaft 14 has advanced within the obturator 12.
  • The distal tip 40 of the marker delivery shaft 14 is configured to penetrate the substantially sealed distal end 22 of the obturator 12 so that tissue markers 36 can be delivered while the obturator 12 is in place within the patient's body. Preferably the distal tip 40 is needle shaped 46 (FIG. 5), however, the distal tip can alternatively be a blunt tip 48 (FIG. 6) which is capable of penetrating a substantially sealed distal end 22 that is formed of a penetrable membrane 28 which is weakened or a distal end 22 with petals 30 or a valve 32.
  • Preferably the marker delivery device 10 also includes a plunger 50 having an elongated shaft 52 with a distal end 54 and a proximal end 56. The plunger 50 is configured to be slidably disposed within the marker delivery lumen 34 and is located proximal to the one or more tissue markers 36 within the marker delivery lumen 34. When the plunger 50 is extended distally within the marker delivery lumen 34 it moves one or more tissue markers toward and eventually through the opening 42 in the distal tip 40 of the marker delivery shaft 14. The plunger 50 preferably has an enlarged proximal end 58 to prevent its entry into the lumen 34. Alternatively, a fluid (not shown) may be used to advance the markers 36 through the opening 42 in the distal tip 40 of the marker delivery tubular shaft 14.
  • FIGS. 7A-7C show the distal tip 40 of the marker delivery tube 14 partially penetrating the substantially sealed distal end 22 of the obturator 12. In other words, as shown in FIGS. 7A-7C, the distal tip 40 of the marker delivery tube 14 has partially punctured the penetrable membrane 28 of the substantially sealed distal end 22 of the obturator 12, and the plunger 50 is not yet deployed. The tissue markers 36 in FIG. 7A-7C are contained within the marker delivery lumen 34.
  • FIGS. 8A-8C show the distal tip 40 completely penetrating the substantially sealed distal end 22 of the obturator 12 and the tissue markers 36 within the marker delivery lumen 34. In other words, as shown in FIGS. 8A-8C, the distal tip 40 of the marker delivery tube 14 has completely punctured the penetrable membrane 28 of the substantially sealed distal end 22 of the obturator 12, and the plunger 50 is not yet deployed.
  • FIGS. 9A-9C show the distal tip 40 of the marker delivery tubular shaft 14 completely penetrating the substantially sealed distal end 22. In other words, as shown in FIGS. 9A-9C, the distal tip 40 of the marker delivery tube 14 has completely punctured the penetrable membrane 28 of the substantially sealed distal end 22 of the obturator 12. In FIGS. 9A-9C the plunger 50 is deployed distally within the marker delivery lumen 34.
  • Preferably the obturator 12 has a hub 60 at the proximal end 20 of the obturator shaft 16. The hub 60 may have gripping ridges 62 which allow a person operating the device 10 to maintain a grip on the device 10. The marker delivery tubular shaft 14 preferably also has a hub 64 at the proximal end of the marker delivery shaft 38 with gripping ridges 66. At least a portion of the hub 64 of the marker delivery tubular shaft 14 is configured to fit within the hub 64 of the obturator 12 when the marker delivery shaft 14 is inserted into the obturator 12.
  • The marker delivery device 10 is preferably formed of a non-magnetic material. A plastic such as MAKROLON®, a polycarbonate from Bayer Material Sciences a division of Bayer AG, is suitable and will not interfere with a magnetic resonance imaging device (MRI). The device may also include a radiopaque material which allows for detection of the device. Alternatively the location of the obturator 12 may be determined by detecting air within the elongated shaft 16 of the obturator 12 with a magnetic resonance imaging device (not shown).
  • A method for delivering a tissue marker to a site within a patient's body includes providing the above described device. The obturator 12 of the device 10 is inserted into a desired location within a patient's body. Preferably the obturator 12 is placed within the cannula 24 of a biopsy device that remains in the patient's body after the biopsy device is removed. The marker delivery tubular shaft 14 is then inserted into the obturator 12 and the distal tip 40 of the tubular shaft 14 is advanced through the substantially sealed distal end 22 of the obturator 12. At least one tissue marker 36 within the marker delivery tubular shaft 14 is then advanced distally through the opening 42 in the distal tip 40 of the marker delivery tubular shaft 14. Preferably a plunger 50 is advanced distally within the tubular shaft 14 so that at least one tissue marker 36 is moved through the opening 42 in the distal tip 40. Alternatively a fluid (not shown) can be used in place of the plunger to move the tissue markers 36 through the distal tip 40.
  • An embodiment of the device having features of the invention, which is shown in FIGS. 10A-10G, includes an obturator 68 having an elongated shaft 70 including a cylindrical wall with an internal lumen 72, a proximal end 74, a substantially sealed distal end 76, and a detectable element 78 capable of producing a relatively significant image signature. Preferably the detectable element 78 is incorporated into the obturator 68 at a location determined to be optimum for complimenting the subsequent procedure.
  • As shown in FIG. 10G, the detectable element 78 preferably is in the form of a ring 80 located near the substantially sealed distal end 76 of the obturator 68. Preferably the substantially sealed distal end 76 of the obturator 68 is located on an obturator tip 82. As shown in FIGS. 10A, 10C, 10F and 10G, the detectable element 78/80 is in contact with the mating surfaces of a terminal distal end of the cylindrical wall of the elongated shaft 70 and the obturator tip 82. The cylindrical wall of the elongated shaft 70 also includes at least one aperture 84 and the obturator tip 82 of the obturator 68 preferably includes a raised tab 86 which extends into the aperture 84 to hold the obturator tip 82 in place. The detectable element 78 in ring form 80 may be placed at the point where the obturator tip 82 and the elongated shaft 70 of the obturator 68 meet, i.e., at the junction between the obturator tip 82 and the terminal distal end of the cylindrical wall of the elongated shaft 70 of the obturator 68.
  • Preferably the detectable element 78 is in a form which allows the internal lumen of the obturator 72 to remain unobstructed, such as a ring 80. The detectable element 78 can also be a small sphere or rod, one or more wires, or a collar. Also any plan-form shape constructed of sheet material, either planar or formed into a non-planar shape. Alternatively, the detectable element 78 may be the entire tip 82 of the obturator 68. Alternatively more than one detectable element 78 could be incorporated into the obturator 68 to be used as a marker capable of determining the depth of the obturator 68 within a patient's body (not shown).
  • FIGS. 11A-C illustrate an alternative embodiment of an object delivery device 90 having features of the invention including an obturator 92 which has an elongated shaft 94, an internal lumen 96, a proximal end 98 and a substantially sealed distal end 100. Preferably, as previously discussed with the other embodiments, the obturator 92 is configured to fit within a cannula of a biopsy device, such as SenoRx's EnCor™ Magnetic Resonance Imaging (MRI) Breast Biopsy System. The substantially sealed distal end 100 of the obturator 92 is configured to prevent or minimize the backflow of fluids, such as body fluids, through the inner lumen 96. A plurality of intracorporeal objects 102, e.g. biopsy site markers, is disposed within the inner lumen 96. A plunger 104 with an enlarged head 106 is slidably disposed in part within the inner lumen 96 proximal to the plurality of intracorporeal objects 102. Distal movement of the plunger 104 pushes the objects 102 through the distal end into a body site. In this embodiment, the intracorporeal objects may not be able to penetrate a membrane, so the substantially sealed distal end 100 may be formed of two or more petals such as shown in FIG. 3 or can be formed of a duck-billed valve such as shown in FIG. 4.
  • Suitable materials for use as the detectable element 78 are metal, ceramic, metal filled plastic, mineral filled plastic, or a radiopaque material. Radiopaque materials such as stainless steel, platinum, gold, iridium, tantalum, tungsten, silver, rhodium, nickel, bismuth or other radiopaque metals, mixtures of radiopaque metals, oxides of radiopaque metals, barium salts, iodine salts, iodinated materials, and combinations thereof are suitable as well. Additionally, MRI contrast agents such as Gadolinium and vitamin E may also be employed.
  • If desired, an imageable stylet may be used within the inner lumen of the sealed obturator to show the axis of the instrument and the depth of the insertion within the body. Preferably the stylet is formed of material which is compatible with MRI and which is seen in MRI generated images. Suitable materials include non-magnetic metals, non-magnetic metal filled plastics, hollow tubes filled at least in part with an MRI visible substance such as Gadolinium or other fluids.
  • While particular forms of the invention have been illustrated and described herein directed to detectable markers, it will be apparent that various modifications and improvements can be made to the invention. For example, the deployed bodies may be therapeutic or diagnostic agents in addition to or in lieu of being markers. Moreover, individual features may be shown or otherwise described in one embodiment and not in others, but those skilled in the art will recognize that individual features of one embodiment of the invention can be combined with any or all the features of another embodiment. Accordingly, it is not intended that the invention be limited to the specific embodiments illustrated.
  • Terms such as “element”, “member”, “component”, “device”, “means”, “portion”, “section”, “steps”, and words of similar import when used herein shall not be construed as invoking the provisions of 35 U.S.C. §112(6) unless the following claims expressly use the term “means” followed by a particular function without reference to a specific structure or the term “step” followed by a particular function without reference to a specific action. All patents and all patent applications referred to above are hereby incorporated by reference in their entirety.

Claims (15)

1. A marker delivery device, comprising:
an obturator having an elongated shaft, an internal lumen, a proximal end, and a substantially sealed distal end, the substantially sealed distal end being formed of a penetrable membrane; and
a marker delivery tube configured to be slidably disposed within the internal lumen of the obturator, the marker delivery tube having a marker delivery lumen, a proximal end, and a distal tip, the marker delivery lumen being configured to contain one or more tissue markers, and the distal tip being configured to puncture the penetrable membrane of the substantially sealed distal end of the obturator to form a passage through which the distal tip extends to facilitate delivery of the one or more tissue markers.
2. The marker delivery device of claim 1, wherein the substantially sealed distal end has a rounded external surface.
3. The marker delivery device of claim 1, wherein the distal tip of the marker delivery tube is needle shaped.
4. The marker delivery device of claim 1, wherein the proximal end of the obturator has a first hub and the proximal end of the marker delivery tubular shaft has a second hub which is configured to fit within the first hub of the obturator when the marker delivery shaft is inserted into the elongated shaft of the obturator.
5. The marker delivery device of claim 1, which is made of non-metallic material.
6. The marker delivery device of claim 1, which is made of non-magnetic material.
7. The marker delivery device of claim 1, wherein the substantially sealed distal end is a sealed distal end.
8. A marker delivery device, comprising:
an obturator having an elongated shaft, an internal lumen, a proximal end, and a rounded distal end formed of a penetrable membrane; and
a marker delivery tube configured to be slidably disposed within the internal lumen of the obturator, the marker delivery tube having a marker delivery lumen, a proximal end, and a distal tip, the marker delivery lumen being configured to contain one or more tissue markers, and the distal tip being configured to puncture the penetrable membrane of the rounded distal end of the obturator to form a passage through which the distal tip extends for delivery of the one or more tissue markers.
9. The marker delivery device of claim 8, wherein the distal tip of the marker delivery tube is needle shaped.
10. The marker delivery device of claim 8, wherein the proximal end of the obturator has a first hub and the proximal end of the marker delivery tubular shaft has a second hub which is configured to fit within the first hub of the obturator when the marker delivery shaft is inserted into the elongated shaft of the obturator.
11. The marker delivery device of claim 8, which is made of non-metallic material.
12. The marker delivery device of claim 8, which is made of non-magnetic material.
13. The marker delivery device of claim 8, wherein the substantially sealed distal end is a sealed distal end.
14. A method for delivering a tissue marker to a site within a body of a patient, comprising:
providing an obturator having an elongated shaft, an internal lumen, a proximal end and a substantially sealed distal end, the substantially sealed distal end being formed of a penetrable membrane;
providing a marker delivery tube containing one or more tissue markers, the marker delivery tube having a distal tip;
slidably disposing the marker delivery tube within the internal lumen of the obturator;
advancing the marker delivery tube within the internal lumen of the obturator toward the penetrable membrane of the substantially sealed distal end of the obturator; and
puncturing the penetrable membrane of the substantially sealed distal end of the obturator with the distal tip of the marker delivery tube to form a passage through which the distal tip extends to facilitate delivery of the one or more tissue markers to the site.
15. The method of claim 14, comprising advancing a plunger through a marker delivery lumen of the marker delivery tube to advance at least one tissue marker through the distal tip of the marker delivery tube to the site.
US13/079,849 2006-08-04 2011-04-05 Marker delivery device with obturator Abandoned US20110184449A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/079,849 US20110184449A1 (en) 2006-08-04 2011-04-05 Marker delivery device with obturator

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/499,466 US7945307B2 (en) 2006-08-04 2006-08-04 Marker delivery system with obturator
US13/079,849 US20110184449A1 (en) 2006-08-04 2011-04-05 Marker delivery device with obturator

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/499,466 Continuation US7945307B2 (en) 2006-08-04 2006-08-04 Marker delivery system with obturator

Publications (1)

Publication Number Publication Date
US20110184449A1 true US20110184449A1 (en) 2011-07-28

Family

ID=38657959

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/499,466 Active 2028-04-29 US7945307B2 (en) 2006-08-04 2006-08-04 Marker delivery system with obturator
US13/079,849 Abandoned US20110184449A1 (en) 2006-08-04 2011-04-05 Marker delivery device with obturator

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US11/499,466 Active 2028-04-29 US7945307B2 (en) 2006-08-04 2006-08-04 Marker delivery system with obturator

Country Status (2)

Country Link
US (2) US7945307B2 (en)
WO (1) WO2008016551A1 (en)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD715442S1 (en) 2013-09-24 2014-10-14 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715942S1 (en) 2013-09-24 2014-10-21 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD716451S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD716450S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
US9042965B2 (en) 2006-12-18 2015-05-26 C. R. Bard, Inc. Biopsy marker with in situ-generated imaging properties
US9044162B2 (en) 1999-02-02 2015-06-02 Senorx, Inc. Marker delivery device with releasable plug
US9149341B2 (en) 1999-02-02 2015-10-06 Senorx, Inc Deployment of polysaccharide markers for treating a site within a patient
WO2016123027A1 (en) * 2015-01-26 2016-08-04 Nano Precision Medical, Inc. Apparatus and method for promoting fluid uptake into an implant
WO2017180792A1 (en) * 2016-04-13 2017-10-19 Cardiac Pacemakers, Inc. Subcutaneous implant integrated instrument with pocket creator
US9820824B2 (en) 1999-02-02 2017-11-21 Senorx, Inc. Deployment of polysaccharide markers for treating a site within a patent
US9901415B2 (en) 2006-12-12 2018-02-27 C. R. Bard, Inc. Multiple imaging mode tissue marker
US10045832B2 (en) 2003-05-23 2018-08-14 Senorx, Inc. Marker or filler forming fluid
US10172674B2 (en) 1999-02-02 2019-01-08 Senorx, Inc. Intracorporeal marker and marker delivery device
US10258428B2 (en) 2008-12-30 2019-04-16 C. R. Bard, Inc. Marker delivery device for tissue marker placement
US10548632B2 (en) 2016-04-13 2020-02-04 Cardiac Pacemakers, Inc. Subcutaneous implant integrated instrument
US10683119B2 (en) 2014-05-23 2020-06-16 Merit Medical Systems, Inc. Marker element, device for making a marker element, and method for making a marker element
US10786604B2 (en) 2008-09-23 2020-09-29 Senorx, Inc. Porous bioabsorbable implant

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6575991B1 (en) 1999-06-17 2003-06-10 Inrad, Inc. Apparatus for the percutaneous marking of a lesion
US20060036158A1 (en) 2003-11-17 2006-02-16 Inrad, Inc. Self-contained, self-piercing, side-expelling marking apparatus
US8131346B2 (en) 2002-11-18 2012-03-06 Bard Peripheral Vascular, Inc. Apparatus and method for implanting a preloaded localization wire
US20050273002A1 (en) 2004-06-04 2005-12-08 Goosen Ryan L Multi-mode imaging marker
US9265523B2 (en) 2011-10-24 2016-02-23 Nico Corporation Surgical access system with navigation element and method of using same
US9387010B2 (en) 2004-10-28 2016-07-12 Nico Corporation Surgical access assembly and method of using same
US9770261B2 (en) * 2004-10-28 2017-09-26 Nico Corporation Surgical access assembly and method of using same
US9186175B2 (en) 2004-10-28 2015-11-17 Nico Corporation Surgical access assembly and method of using same
US8419656B2 (en) 2004-11-22 2013-04-16 Bard Peripheral Vascular, Inc. Post decompression marker introducer system
US8409111B2 (en) 2004-11-22 2013-04-02 Bard Peripheral Vascular, Inc. Removable localizing wire
US10357328B2 (en) 2005-04-20 2019-07-23 Bard Peripheral Vascular, Inc. and Bard Shannon Limited Marking device with retractable cannula
US8066730B2 (en) * 2005-11-14 2011-11-29 Scapa Flow, Llc Medical dilator system or dilator device
ES2443526T3 (en) 2006-10-23 2014-02-19 C.R. Bard, Inc. Breast marker
US20080125766A1 (en) * 2006-11-24 2008-05-29 Senorx, Inc. MRI imageable assembly
ES2507557T3 (en) * 2006-11-24 2014-10-15 Senorx, Inc. MRI detectable shutter
US8326401B2 (en) 2006-11-24 2012-12-04 Senorx, Inc. MRI detectable obturator
WO2009099767A2 (en) 2008-01-31 2009-08-13 C.R. Bard, Inc. Biopsy tissue marker
US8068895B2 (en) * 2008-02-25 2011-11-29 Devicor Medical Products, Inc. Biopsy site marker deployment instrument
US8079964B2 (en) * 2008-02-25 2011-12-20 Devicor Medical Products, Inc. Method and apparatus for inserting biopsy site marker in marker body
US8307824B2 (en) * 2008-06-27 2012-11-13 Kimberly-Clark Worldwide, Inc. Method of performing a tracheostomy
US8050742B2 (en) * 2008-07-30 2011-11-01 Devicor Medical Products, Inc. Biopsy device
US9042964B2 (en) * 2009-04-30 2015-05-26 Cook Medical Technologies Llc System and method for fiducial deployment via slotted needle
US20110160539A1 (en) * 2009-12-29 2011-06-30 Boston Scientific Scimed, Inc. Expandable member dissection port
US9309019B2 (en) 2010-05-21 2016-04-12 Adhezion Biomedical, Llc Low dose gamma sterilization of liquid adhesives
US8550737B2 (en) 2010-09-20 2013-10-08 Adhezion Biomedical, Llc Applicators for dispensing adhesive or sealant material
US8838208B2 (en) 2011-06-28 2014-09-16 Cook Medical Technologies Llc Fiducial deployment needle system
US9066711B2 (en) 2011-11-02 2015-06-30 Adhezion Biomedical, Llc Applicators for storing sterilizing, and dispensing an adhesive
US9757147B2 (en) 2012-04-11 2017-09-12 Nico Corporation Surgical access system with navigation element and method of using same
CN102697540B (en) * 2012-06-26 2013-10-30 江苏蓝域创新技术投资有限公司 Needle used for puncturing and positioning pulmonary nodule
EP2967642B1 (en) 2013-02-26 2017-02-01 Cook Medical Technologies LLC Ratchet-slide handle and system for fiducial deployment
US11311312B2 (en) * 2013-03-15 2022-04-26 Medtronic, Inc. Subcutaneous delivery tool
USD1010108S1 (en) 2013-03-15 2024-01-02 Medtronic, Inc. Plunger
US9155527B2 (en) 2013-08-22 2015-10-13 Transmed7, Llc Soft tissue coring biopsy devices and methods
EP3043719B1 (en) 2013-09-12 2022-04-13 Transmed7, LLC Tissue coring biopsy devices
EP3151764B1 (en) 2014-06-09 2023-02-01 Cook Medical Technologies LLC Screw-driven handles and systems for fiducial deployment
CN106456150B (en) * 2014-06-16 2019-02-12 库克医药技术有限责任公司 Plunger type collet handle and system for primary standard substance deployment
US9999758B2 (en) 2014-09-19 2018-06-19 Transmed7, Llc In-situ material delivery devices and methods
USD806237S1 (en) * 2014-09-30 2017-12-26 Pheneo Gmbh Applicator
US10123848B2 (en) 2014-12-03 2018-11-13 Cook Medical Technologies Llc EUS fiducial needle stylet handle assembly
USD790699S1 (en) * 2015-03-25 2017-06-27 Medtronic Ps Medical, Inc. Surgical tool
USD800907S1 (en) 2015-03-25 2017-10-24 Medtronic Ps Medical, Inc. Surgical tool
USD800906S1 (en) 2015-03-25 2017-10-24 Medtronic Ps Medical, Inc. Surgical tool
US10314610B2 (en) 2015-03-25 2019-06-11 Medtronic Ps Medical, Inc. Slanted drive axis rotary surgical cutting tools and powered handpieces
USD782042S1 (en) * 2015-03-25 2017-03-21 Medtronic Ps Medical, Inc. Surgical tool
US10080579B2 (en) 2015-03-25 2018-09-25 Medtronic Ps Medical, Inc. Pin drive rotary surgical cutting tools and powered handpieces
US20160287795A1 (en) * 2015-04-02 2016-10-06 XEND Medical, LLC Method of using a hypodermic needle system
US20170065805A1 (en) * 2015-09-04 2017-03-09 The Sotopelle Group, Llc Therapeutic trocar/inserter and method of use
JP6914932B2 (en) 2015-11-11 2021-08-04 デビコー・メディカル・プロダクツ・インコーポレイテッドDevicor Medical Products, Inc. Marker sending device and how to deploy markers
WO2017083417A1 (en) * 2015-11-12 2017-05-18 Devicor Medical Products, Inc. Marker delivery device and method of deploying a marker
USD800903S1 (en) 2016-02-09 2017-10-24 Medtronic Ps Medical, Inc. Surgical tool
US10335124B1 (en) * 2016-02-29 2019-07-02 Devicor Medical Products, Inc. Marker delivery device with adaptor for biopsy site marking and method of use thereof
US9956055B2 (en) * 2016-05-17 2018-05-01 Eli Halpert Marking device with metallic element for use in X-ray guided surgery
US10952686B2 (en) 2016-08-02 2021-03-23 Medtronic, Inc. Mobile application to prompt physical action to measure physiologic response in implantable device
WO2019165131A1 (en) * 2018-02-21 2019-08-29 Virden Charles P Atraumatic subcutaneous medication delivery
US10856907B2 (en) 2018-02-21 2020-12-08 Charles P. Virden Atraumatic trocar medication delivery method
US11406806B2 (en) 2018-02-21 2022-08-09 Charles P. Virden Atraumatic trocar apparatus, system and kit
US10849634B2 (en) 2018-06-20 2020-12-01 Medtronic Xomed, Inc. Coupling portion for rotary surgical cutting systems
EA033056B1 (en) * 2018-08-28 2019-08-30 Общество С Ограниченной Ответственностью "Онколинн" (Ооо "Онколинн") Method for labelling a biological tissue and device for implementation thereof
WO2021003154A1 (en) * 2019-07-02 2021-01-07 Musc Foundation For Research Development Minimally invasive subdural evacuating system
US11717186B2 (en) 2019-08-27 2023-08-08 Medtronic, Inc. Body stability measurement
CN116249496A (en) * 2020-05-20 2023-06-09 波士顿科学有限公司 Medical delivery system and method of use thereof
USD945622S1 (en) 2020-06-25 2022-03-08 Medtronic, Inc. Implantable medical device
US11602313B2 (en) 2020-07-28 2023-03-14 Medtronic, Inc. Determining a fall risk responsive to detecting body position movements

Citations (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2192270A (en) * 1938-05-25 1940-03-05 American Brake Co Brake rigging
US2481408A (en) * 1946-08-13 1949-09-06 Olin Mathieson Regeneration of caustic soda-sodium sulfide cooking liquor
US2832888A (en) * 1956-05-17 1958-04-29 David R Houston Box car detector
US2899362A (en) * 1959-08-11 Hemostatic sponges and method of
US2907327A (en) * 1957-02-08 1959-10-06 Pfizer & Co C Pellet implanter
US3005457A (en) * 1957-04-01 1961-10-24 Ortho Pharma Corp Methyl cellulose sponge and method of making
US3341417A (en) * 1965-07-14 1967-09-12 Edwin S Sinaiko Method of and means for diagnosis of ingested drugs with radio-opaque and other indicators
US3402712A (en) * 1966-07-19 1968-09-24 American Home Prod Pellet implanter
US3516412A (en) * 1965-08-16 1970-06-23 Electro Catheter Corp Bipolar electrode having irregularity at inserting end thereof and method of insertion
US3593343A (en) * 1968-07-19 1971-07-20 Robert F Viggers Prosthetic ball-check heart valve
US3757781A (en) * 1971-09-17 1973-09-11 R Smart Tool for administering pills to animals
US3818894A (en) * 1971-01-22 1974-06-25 Ceskoslovenska Akademie Ved Laryngeal implant
US3823212A (en) * 1968-11-27 1974-07-09 Freudenberg C Fa Process for the production of collagen fiber fabrics in the form of felt-like membranes or sponge-like layers
US3921632A (en) * 1974-08-16 1975-11-25 Frank M Bardani Implant device
US4005699A (en) * 1974-10-09 1977-02-01 Louis Bucalo Methods and apparatus for use in magnetic treatment of the body
US4007732A (en) * 1975-09-02 1977-02-15 Robert Carl Kvavle Method for location and removal of soft tissue in human biopsy operations
US4041931A (en) * 1976-05-17 1977-08-16 Elliott Donald P Radiopaque anastomosis marker
US4103690A (en) * 1977-03-21 1978-08-01 Cordis Corporation Self-suturing cardiac pacer lead
US4105030A (en) * 1977-01-03 1978-08-08 Syntex (U.S.A.) Inc. Implant apparatus
US4172449A (en) * 1978-05-01 1979-10-30 New Research And Development Laboratories, Inc. Body fluid pressure monitor
US4197846A (en) * 1974-10-09 1980-04-15 Louis Bucalo Method for structure for situating in a living body agents for treating the body
US4217889A (en) * 1976-09-15 1980-08-19 Heyer-Schulte Corporation Flap development device and method of progressively increasing skin area
US4276885A (en) * 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
US4294241A (en) * 1977-06-09 1981-10-13 Teruo Miyata Collagen skin dressing
US4298998A (en) * 1980-12-08 1981-11-10 Naficy Sadeque S Breast prosthesis with biologically absorbable outer container
US4331654A (en) * 1980-06-13 1982-05-25 Eli Lilly And Company Magnetically-localizable, biodegradable lipid microspheres
US4390018A (en) * 1980-09-15 1983-06-28 Zukowski Henry J Method for preventing loss of spinal fluid after spinal tap
US4400170A (en) * 1981-09-29 1983-08-23 Syntex (U.S.A.) Inc. Implanting device and implant magazine
US4401124A (en) * 1981-08-13 1983-08-30 Technicare Corporation Reflection enhancement of a biopsy needle
US4405314A (en) * 1982-04-19 1983-09-20 Cook Incorporated Apparatus and method for catheterization permitting use of a smaller gage needle
US4428082A (en) * 1980-12-08 1984-01-31 Naficy Sadeque S Breast prosthesis with filling valve
US4438253A (en) * 1982-11-12 1984-03-20 American Cyanamid Company Poly(glycolic acid)/poly(alkylene glycol) block copolymers and method of manufacturing the same
US4442843A (en) * 1980-11-17 1984-04-17 Schering, Ag Microbubble precursors and methods for their production and use
US4470160A (en) * 1980-11-21 1984-09-11 Cavon Joseph F Cast gel implantable prosthesis
US4487209A (en) * 1981-03-16 1984-12-11 Creative Research And Manufacturing Inc. Biopsy needle
US4545367A (en) * 1982-07-16 1985-10-08 Cordis Corporation Detachable balloon catheter and method of use
US4549560A (en) * 1984-03-19 1985-10-29 Andis Company Hair curling appliance with elastomer material covering heating element
US4582061A (en) * 1981-11-18 1986-04-15 Indianapolis Center For Advanced Research, Inc. Needle with ultrasonically reflective displacement scale
US4582640A (en) * 1982-03-08 1986-04-15 Collagen Corporation Injectable cross-linked collagen implant material
US4588395A (en) * 1978-03-10 1986-05-13 Lemelson Jerome H Catheter and method
US4597753A (en) * 1983-04-21 1986-07-01 Hundon Forge Limited Implanting method and device
US4647480A (en) * 1983-07-25 1987-03-03 Amchem Products, Inc. Use of additive in aqueous cure of autodeposited coatings
US4655226A (en) * 1983-12-16 1987-04-07 Southland Instruments, Inc. Disposable biopsy needle unit
US4661103A (en) * 1986-03-03 1987-04-28 Engineering Development Associates, Ltd. Multiple implant injector
US4682606A (en) * 1986-02-03 1987-07-28 Decaprio Vincent H Localizing biopsy apparatus
US4693237A (en) * 1986-01-21 1987-09-15 Hoffman Richard B Radiopaque coded ring markers for use in identifying surgical grafts
US4740208A (en) * 1980-11-21 1988-04-26 Cavon Joseph F Cast gel implantable prosthesis
US4762128A (en) * 1986-12-09 1988-08-09 Advanced Surgical Intervention, Inc. Method and apparatus for treating hypertrophy of the prostate gland
US4813062A (en) * 1986-08-13 1989-03-14 Milliken Research Corporation Radio-opaque marker and method
US4820267A (en) * 1985-02-19 1989-04-11 Endocon, Inc. Cartridge injector for pellet medicaments
US4832686A (en) * 1986-06-24 1989-05-23 Anderson Mark E Method for administering interleukin-2
US4832680A (en) * 1986-07-03 1989-05-23 C.R. Bard, Inc. Apparatus for hypodermically implanting a genitourinary prosthesis
US4847049A (en) * 1985-12-18 1989-07-11 Vitaphore Corporation Method of forming chelated collagen having bactericidal properties
US4863470A (en) * 1985-03-19 1989-09-05 Medical Engineering Corporation Identification marker for a breast prosthesis
US4870966A (en) * 1988-02-01 1989-10-03 American Cyanamid Company Bioabsorbable surgical device for treating nerve defects
US4874376A (en) * 1987-04-13 1989-10-17 Hawkins Jr Irvin F Needle guide assembly
US4889707A (en) * 1988-01-29 1989-12-26 The Curators Of The University Of Missouri Composition and method for radiation synovectomy of arthritic joints
US4909250A (en) * 1988-11-14 1990-03-20 Smith Joseph R Implant system for animal identification
US4938763A (en) * 1988-10-03 1990-07-03 Dunn Richard L Biodegradable in-situ forming implants and methods of producing the same
US4950234A (en) * 1987-05-26 1990-08-21 Sumitomo Pharmaceuticals Company, Limited Device for administering solid preparations
US4950665A (en) * 1988-10-28 1990-08-21 Oklahoma Medical Research Foundation Phototherapy using methylene blue
US4963150A (en) * 1984-08-30 1990-10-16 Daniel Brauman Implantable prosthetic devices
US4970298A (en) * 1984-03-27 1990-11-13 University Of Medicine And Dentistry Of New Jersey Biodegradable matrix and methods for producing same
US4989608A (en) * 1987-07-02 1991-02-05 Ratner Adam V Device construction and method facilitating magnetic resonance imaging of foreign objects in a body
US4994028A (en) * 1987-03-18 1991-02-19 Endocon, Inc. Injector for inplanting multiple pellet medicaments
US4994013A (en) * 1988-07-28 1991-02-19 Best Industries, Inc. Pellet for a radioactive seed
US5012818A (en) * 1989-05-04 1991-05-07 Joishy Suresh K Two in one bone marrow surgical needle
US5018530A (en) * 1989-06-15 1991-05-28 Research Corporation Technologies, Inc. Helical-tipped lesion localization needle device and method of using the same
US5035891A (en) * 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
US5059197A (en) * 1989-04-15 1991-10-22 Urie Robert G Lesion location device
US5081997A (en) * 1989-03-09 1992-01-21 Vance Products Incorporated Echogenic devices, material and method
US5120802A (en) * 1987-12-17 1992-06-09 Allied-Signal Inc. Polycarbonate-based block copolymers and devices
US5125413A (en) * 1989-03-29 1992-06-30 Baran Gregory W Automated biopsy instrument
US5137928A (en) * 1990-04-26 1992-08-11 Hoechst Aktiengesellschaft Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents
US5141748A (en) * 1989-02-17 1992-08-25 Hoffmann-La Roche, Inc. Implant drug delivery device
US5147307A (en) * 1991-06-17 1992-09-15 Gluck Seymour M Anatomical marker device and method
US5147631A (en) * 1991-04-30 1992-09-15 Du Pont Merck Pharmaceutical Company Porous inorganic ultrasound contrast agents
US5162430A (en) * 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
US5195540A (en) * 1991-08-12 1993-03-23 Samuel Shiber Lesion marking process
US5197482A (en) * 1989-06-15 1993-03-30 Research Corporation Technologies, Inc. Helical-tipped lesion localization needle device and method of using the same
US5197846A (en) * 1989-12-22 1993-03-30 Hitachi, Ltd. Six-degree-of-freedom articulated robot mechanism and assembling and working apparatus using same
US5199441A (en) * 1991-08-20 1993-04-06 Hogle Hugh H Fine needle aspiration biopsy apparatus and method
US5219339A (en) * 1989-11-17 1993-06-15 Masataka Saito Single use medical needle
US5221269A (en) * 1990-10-15 1993-06-22 Cook Incorporated Guide for localizing a nonpalpable breast lesion
US5231615A (en) * 1990-04-23 1993-07-27 Teac Corporation Carriage fixing apparatus and disk driver having such carriage fixing apparatus
US5234426A (en) * 1989-06-15 1993-08-10 Research Corporation Technologies, Inc. Helical-tipped lesion localization needle device and method of using the same
US5236410A (en) * 1990-08-02 1993-08-17 Ferrotherm International, Inc. Tumor treatment method
US5242759A (en) * 1991-05-21 1993-09-07 Cook Incorporated Joint, a laminate, and a method of preparing a nickel-titanium alloy member surface for bonding to another layer of metal
US5250026A (en) * 1992-05-27 1993-10-05 Destron/Idi, Inc. Adjustable precision transponder injector
US5271961A (en) * 1989-11-06 1993-12-21 Alkermes Controlled Therapeutics, Inc. Method for producing protein microspheres
US5273532A (en) * 1991-09-03 1993-12-28 Texas Instruments Incorporated Injector for hypodermically implanting an object in a living being
US5280788A (en) * 1991-02-26 1994-01-25 Massachusetts Institute Of Technology Devices and methods for optical diagnosis of tissue
US5281408A (en) * 1991-04-05 1994-01-25 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5281197A (en) * 1992-07-27 1994-01-25 Symbiosis Corporation Endoscopic hemostatic agent delivery system
US5282781A (en) * 1990-10-25 1994-02-01 Omnitron International Inc. Source wire for localized radiation treatment of tumors
US5284479A (en) * 1989-08-30 1994-02-08 N.V. Nederlandsche Apparatenfabriek Nedap Implanter
US20040068312A1 (en) * 2002-10-02 2004-04-08 Medtronic, Inc. Delivery of active fixation implatable lead systems
US20040236213A1 (en) * 2003-05-23 2004-11-25 Senorx, Inc. Marker delivery device with releasable plug

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5800389A (en) * 1996-02-09 1998-09-01 Emx, Inc. Biopsy device
US5845646A (en) * 1996-11-05 1998-12-08 Lemelson; Jerome System and method for treating select tissue in a living being
US6347241B2 (en) 1999-02-02 2002-02-12 Senorx, Inc. Ultrasonic and x-ray detectable biopsy site marker and apparatus for applying it
US6161034A (en) 1999-02-02 2000-12-12 Senorx, Inc. Methods and chemical preparations for time-limited marking of biopsy sites
US6725083B1 (en) 1999-02-02 2004-04-20 Senorx, Inc. Tissue site markers for in VIVO imaging
US6862470B2 (en) * 1999-02-02 2005-03-01 Senorx, Inc. Cavity-filling biopsy site markers
AU768362B2 (en) * 1999-06-05 2003-12-11 Cook Medical Technologies Llc Indicia for an endoscopic medical device
EP1114618A3 (en) 2000-01-04 2001-08-22 Ethicon Endo-Surgery, Inc. Surgical instrument for applying beads to tissue
WO2002041786A2 (en) 2000-11-20 2002-05-30 Senorx, Inc. Tissue site markers for in vivo imaging
US6939318B2 (en) * 2002-05-03 2005-09-06 Boston Scientific Scimed, Inc. Method, tool, and system for deploying an implant into the body
US7166133B2 (en) * 2002-06-13 2007-01-23 Kensey Nash Corporation Devices and methods for treating defects in the tissue of a living being
FR2853521B1 (en) * 2003-04-10 2005-12-02 Claude Mialhe DEVICE FOR EXPANDING A VESSEL AND INTRODUCING VASCULAR IMPLANT

Patent Citations (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2899362A (en) * 1959-08-11 Hemostatic sponges and method of
US2192270A (en) * 1938-05-25 1940-03-05 American Brake Co Brake rigging
US2481408A (en) * 1946-08-13 1949-09-06 Olin Mathieson Regeneration of caustic soda-sodium sulfide cooking liquor
US2832888A (en) * 1956-05-17 1958-04-29 David R Houston Box car detector
US2907327A (en) * 1957-02-08 1959-10-06 Pfizer & Co C Pellet implanter
US3005457A (en) * 1957-04-01 1961-10-24 Ortho Pharma Corp Methyl cellulose sponge and method of making
US3341417A (en) * 1965-07-14 1967-09-12 Edwin S Sinaiko Method of and means for diagnosis of ingested drugs with radio-opaque and other indicators
US3516412A (en) * 1965-08-16 1970-06-23 Electro Catheter Corp Bipolar electrode having irregularity at inserting end thereof and method of insertion
US3402712A (en) * 1966-07-19 1968-09-24 American Home Prod Pellet implanter
US3593343A (en) * 1968-07-19 1971-07-20 Robert F Viggers Prosthetic ball-check heart valve
US3823212A (en) * 1968-11-27 1974-07-09 Freudenberg C Fa Process for the production of collagen fiber fabrics in the form of felt-like membranes or sponge-like layers
US3818894A (en) * 1971-01-22 1974-06-25 Ceskoslovenska Akademie Ved Laryngeal implant
US3757781A (en) * 1971-09-17 1973-09-11 R Smart Tool for administering pills to animals
US3921632A (en) * 1974-08-16 1975-11-25 Frank M Bardani Implant device
US4197846A (en) * 1974-10-09 1980-04-15 Louis Bucalo Method for structure for situating in a living body agents for treating the body
US4005699A (en) * 1974-10-09 1977-02-01 Louis Bucalo Methods and apparatus for use in magnetic treatment of the body
US4007732A (en) * 1975-09-02 1977-02-15 Robert Carl Kvavle Method for location and removal of soft tissue in human biopsy operations
US4041931A (en) * 1976-05-17 1977-08-16 Elliott Donald P Radiopaque anastomosis marker
US4217889A (en) * 1976-09-15 1980-08-19 Heyer-Schulte Corporation Flap development device and method of progressively increasing skin area
US4105030A (en) * 1977-01-03 1978-08-08 Syntex (U.S.A.) Inc. Implant apparatus
US4103690A (en) * 1977-03-21 1978-08-01 Cordis Corporation Self-suturing cardiac pacer lead
US4294241A (en) * 1977-06-09 1981-10-13 Teruo Miyata Collagen skin dressing
US4588395A (en) * 1978-03-10 1986-05-13 Lemelson Jerome H Catheter and method
US4172449A (en) * 1978-05-01 1979-10-30 New Research And Development Laboratories, Inc. Body fluid pressure monitor
US4276885A (en) * 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
US4331654A (en) * 1980-06-13 1982-05-25 Eli Lilly And Company Magnetically-localizable, biodegradable lipid microspheres
US4390018A (en) * 1980-09-15 1983-06-28 Zukowski Henry J Method for preventing loss of spinal fluid after spinal tap
US4442843A (en) * 1980-11-17 1984-04-17 Schering, Ag Microbubble precursors and methods for their production and use
US4740208A (en) * 1980-11-21 1988-04-26 Cavon Joseph F Cast gel implantable prosthesis
US4470160A (en) * 1980-11-21 1984-09-11 Cavon Joseph F Cast gel implantable prosthesis
US4428082A (en) * 1980-12-08 1984-01-31 Naficy Sadeque S Breast prosthesis with filling valve
US4298998A (en) * 1980-12-08 1981-11-10 Naficy Sadeque S Breast prosthesis with biologically absorbable outer container
US4487209A (en) * 1981-03-16 1984-12-11 Creative Research And Manufacturing Inc. Biopsy needle
US4401124A (en) * 1981-08-13 1983-08-30 Technicare Corporation Reflection enhancement of a biopsy needle
US4400170A (en) * 1981-09-29 1983-08-23 Syntex (U.S.A.) Inc. Implanting device and implant magazine
US4582061A (en) * 1981-11-18 1986-04-15 Indianapolis Center For Advanced Research, Inc. Needle with ultrasonically reflective displacement scale
US4582640A (en) * 1982-03-08 1986-04-15 Collagen Corporation Injectable cross-linked collagen implant material
US4405314A (en) * 1982-04-19 1983-09-20 Cook Incorporated Apparatus and method for catheterization permitting use of a smaller gage needle
US4545367A (en) * 1982-07-16 1985-10-08 Cordis Corporation Detachable balloon catheter and method of use
US4438253A (en) * 1982-11-12 1984-03-20 American Cyanamid Company Poly(glycolic acid)/poly(alkylene glycol) block copolymers and method of manufacturing the same
US4597753A (en) * 1983-04-21 1986-07-01 Hundon Forge Limited Implanting method and device
US4647480A (en) * 1983-07-25 1987-03-03 Amchem Products, Inc. Use of additive in aqueous cure of autodeposited coatings
US4655226A (en) * 1983-12-16 1987-04-07 Southland Instruments, Inc. Disposable biopsy needle unit
US4549560A (en) * 1984-03-19 1985-10-29 Andis Company Hair curling appliance with elastomer material covering heating element
US4970298A (en) * 1984-03-27 1990-11-13 University Of Medicine And Dentistry Of New Jersey Biodegradable matrix and methods for producing same
US4963150A (en) * 1984-08-30 1990-10-16 Daniel Brauman Implantable prosthetic devices
US4963150B1 (en) * 1984-08-30 1994-10-04 Daniel Brauman Implantable prosthetic device
US4820267A (en) * 1985-02-19 1989-04-11 Endocon, Inc. Cartridge injector for pellet medicaments
US4863470A (en) * 1985-03-19 1989-09-05 Medical Engineering Corporation Identification marker for a breast prosthesis
US4847049A (en) * 1985-12-18 1989-07-11 Vitaphore Corporation Method of forming chelated collagen having bactericidal properties
US4693237A (en) * 1986-01-21 1987-09-15 Hoffman Richard B Radiopaque coded ring markers for use in identifying surgical grafts
US4682606A (en) * 1986-02-03 1987-07-28 Decaprio Vincent H Localizing biopsy apparatus
US4661103A (en) * 1986-03-03 1987-04-28 Engineering Development Associates, Ltd. Multiple implant injector
US4832686A (en) * 1986-06-24 1989-05-23 Anderson Mark E Method for administering interleukin-2
US4832680A (en) * 1986-07-03 1989-05-23 C.R. Bard, Inc. Apparatus for hypodermically implanting a genitourinary prosthesis
US4813062A (en) * 1986-08-13 1989-03-14 Milliken Research Corporation Radio-opaque marker and method
US4762128A (en) * 1986-12-09 1988-08-09 Advanced Surgical Intervention, Inc. Method and apparatus for treating hypertrophy of the prostate gland
US4994028A (en) * 1987-03-18 1991-02-19 Endocon, Inc. Injector for inplanting multiple pellet medicaments
US4874376A (en) * 1987-04-13 1989-10-17 Hawkins Jr Irvin F Needle guide assembly
US4950234A (en) * 1987-05-26 1990-08-21 Sumitomo Pharmaceuticals Company, Limited Device for administering solid preparations
US4989608A (en) * 1987-07-02 1991-02-05 Ratner Adam V Device construction and method facilitating magnetic resonance imaging of foreign objects in a body
US5035891A (en) * 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
US5120802A (en) * 1987-12-17 1992-06-09 Allied-Signal Inc. Polycarbonate-based block copolymers and devices
US4889707A (en) * 1988-01-29 1989-12-26 The Curators Of The University Of Missouri Composition and method for radiation synovectomy of arthritic joints
US4870966A (en) * 1988-02-01 1989-10-03 American Cyanamid Company Bioabsorbable surgical device for treating nerve defects
US5163896A (en) * 1988-07-28 1992-11-17 Best Industries, Inc. Pellet for a radioactive seed
US4994013A (en) * 1988-07-28 1991-02-19 Best Industries, Inc. Pellet for a radioactive seed
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US4938763A (en) * 1988-10-03 1990-07-03 Dunn Richard L Biodegradable in-situ forming implants and methods of producing the same
US4950665A (en) * 1988-10-28 1990-08-21 Oklahoma Medical Research Foundation Phototherapy using methylene blue
US4909250A (en) * 1988-11-14 1990-03-20 Smith Joseph R Implant system for animal identification
US5162430A (en) * 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
US5141748A (en) * 1989-02-17 1992-08-25 Hoffmann-La Roche, Inc. Implant drug delivery device
US5081997A (en) * 1989-03-09 1992-01-21 Vance Products Incorporated Echogenic devices, material and method
US5125413A (en) * 1989-03-29 1992-06-30 Baran Gregory W Automated biopsy instrument
US5059197A (en) * 1989-04-15 1991-10-22 Urie Robert G Lesion location device
US5012818A (en) * 1989-05-04 1991-05-07 Joishy Suresh K Two in one bone marrow surgical needle
US5234426A (en) * 1989-06-15 1993-08-10 Research Corporation Technologies, Inc. Helical-tipped lesion localization needle device and method of using the same
US5018530A (en) * 1989-06-15 1991-05-28 Research Corporation Technologies, Inc. Helical-tipped lesion localization needle device and method of using the same
US5197482A (en) * 1989-06-15 1993-03-30 Research Corporation Technologies, Inc. Helical-tipped lesion localization needle device and method of using the same
US5284479A (en) * 1989-08-30 1994-02-08 N.V. Nederlandsche Apparatenfabriek Nedap Implanter
US5271961A (en) * 1989-11-06 1993-12-21 Alkermes Controlled Therapeutics, Inc. Method for producing protein microspheres
US5219339A (en) * 1989-11-17 1993-06-15 Masataka Saito Single use medical needle
US5197846A (en) * 1989-12-22 1993-03-30 Hitachi, Ltd. Six-degree-of-freedom articulated robot mechanism and assembling and working apparatus using same
US5231615A (en) * 1990-04-23 1993-07-27 Teac Corporation Carriage fixing apparatus and disk driver having such carriage fixing apparatus
US5137928A (en) * 1990-04-26 1992-08-11 Hoechst Aktiengesellschaft Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents
US5236410A (en) * 1990-08-02 1993-08-17 Ferrotherm International, Inc. Tumor treatment method
US5221269A (en) * 1990-10-15 1993-06-22 Cook Incorporated Guide for localizing a nonpalpable breast lesion
US5282781A (en) * 1990-10-25 1994-02-01 Omnitron International Inc. Source wire for localized radiation treatment of tumors
US5280788A (en) * 1991-02-26 1994-01-25 Massachusetts Institute Of Technology Devices and methods for optical diagnosis of tissue
US5281408A (en) * 1991-04-05 1994-01-25 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5147631A (en) * 1991-04-30 1992-09-15 Du Pont Merck Pharmaceutical Company Porous inorganic ultrasound contrast agents
US5242759A (en) * 1991-05-21 1993-09-07 Cook Incorporated Joint, a laminate, and a method of preparing a nickel-titanium alloy member surface for bonding to another layer of metal
US5147307A (en) * 1991-06-17 1992-09-15 Gluck Seymour M Anatomical marker device and method
US5195540A (en) * 1991-08-12 1993-03-23 Samuel Shiber Lesion marking process
US5199441A (en) * 1991-08-20 1993-04-06 Hogle Hugh H Fine needle aspiration biopsy apparatus and method
US5273532A (en) * 1991-09-03 1993-12-28 Texas Instruments Incorporated Injector for hypodermically implanting an object in a living being
US5250026A (en) * 1992-05-27 1993-10-05 Destron/Idi, Inc. Adjustable precision transponder injector
US5281197A (en) * 1992-07-27 1994-01-25 Symbiosis Corporation Endoscopic hemostatic agent delivery system
US20040068312A1 (en) * 2002-10-02 2004-04-08 Medtronic, Inc. Delivery of active fixation implatable lead systems
US20040236213A1 (en) * 2003-05-23 2004-11-25 Senorx, Inc. Marker delivery device with releasable plug

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Mammotome: advancing breast biopsy technology, accesed 12/28/2013 *

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9044162B2 (en) 1999-02-02 2015-06-02 Senorx, Inc. Marker delivery device with releasable plug
US10172674B2 (en) 1999-02-02 2019-01-08 Senorx, Inc. Intracorporeal marker and marker delivery device
US9861294B2 (en) 1999-02-02 2018-01-09 Senorx, Inc. Marker delivery device with releasable plug
US9820824B2 (en) 1999-02-02 2017-11-21 Senorx, Inc. Deployment of polysaccharide markers for treating a site within a patent
US9149341B2 (en) 1999-02-02 2015-10-06 Senorx, Inc Deployment of polysaccharide markers for treating a site within a patient
US10045832B2 (en) 2003-05-23 2018-08-14 Senorx, Inc. Marker or filler forming fluid
US10299881B2 (en) 2003-05-23 2019-05-28 Senorx, Inc. Marker or filler forming fluid
US9901415B2 (en) 2006-12-12 2018-02-27 C. R. Bard, Inc. Multiple imaging mode tissue marker
US11471244B2 (en) 2006-12-12 2022-10-18 C.R. Bard, Inc. Multiple imaging mode tissue marker
US10682200B2 (en) 2006-12-12 2020-06-16 C. R. Bard, Inc. Multiple imaging mode tissue marker
US9042965B2 (en) 2006-12-18 2015-05-26 C. R. Bard, Inc. Biopsy marker with in situ-generated imaging properties
US10786604B2 (en) 2008-09-23 2020-09-29 Senorx, Inc. Porous bioabsorbable implant
US11833275B2 (en) 2008-09-23 2023-12-05 Senorx, Inc. Porous bioabsorbable implant
US10258428B2 (en) 2008-12-30 2019-04-16 C. R. Bard, Inc. Marker delivery device for tissue marker placement
US11779431B2 (en) 2008-12-30 2023-10-10 C. R. Bard, Inc. Marker delivery device for tissue marker placement
USD716450S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715942S1 (en) 2013-09-24 2014-10-21 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD716451S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715442S1 (en) 2013-09-24 2014-10-14 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
US10683119B2 (en) 2014-05-23 2020-06-16 Merit Medical Systems, Inc. Marker element, device for making a marker element, and method for making a marker element
WO2016123027A1 (en) * 2015-01-26 2016-08-04 Nano Precision Medical, Inc. Apparatus and method for promoting fluid uptake into an implant
US10525248B2 (en) 2015-01-26 2020-01-07 Nano Precision Medical, Inc. Apparatus and method for promoting fluid uptake into an implant
US10729463B2 (en) 2016-04-13 2020-08-04 Cardiac Pacemakers, Inc. Subcutaneous implant integrated instrument with pocket creator
WO2017180792A1 (en) * 2016-04-13 2017-10-19 Cardiac Pacemakers, Inc. Subcutaneous implant integrated instrument with pocket creator
US11426202B2 (en) 2016-04-13 2022-08-30 Cardiac Pacemakers, Inc. Subcutaneous implant integrated instrument
US11730513B2 (en) 2016-04-13 2023-08-22 Cardiac Pacemakers, Inc. Subcutaneous implant integrated instrument with pocket creator
US10548632B2 (en) 2016-04-13 2020-02-04 Cardiac Pacemakers, Inc. Subcutaneous implant integrated instrument

Also Published As

Publication number Publication date
US20080033280A1 (en) 2008-02-07
US7945307B2 (en) 2011-05-17
WO2008016551A1 (en) 2008-02-07

Similar Documents

Publication Publication Date Title
US7945307B2 (en) Marker delivery system with obturator
EP2097021B1 (en) Mri imageable assembly
US5954670A (en) Mandrel-guided tandem multiple channel biopsy guide device and method of use
US5057085A (en) Stabilized aspiration biopsy needle assembly
US20090171198A1 (en) Powdered marker
US20100204570A1 (en) Anchor markers
US8326401B2 (en) MRI detectable obturator
AU2012275765B2 (en) System for fiducial deployment
JP6122476B2 (en) Reference marker deployment system
US8554309B2 (en) Localizing obturator with site marking capability
JP2011518639A (en) Assembly with hemostatic and radiation detectable pellets
US20120078087A1 (en) Tissue Localization Device and Method
US20080200834A1 (en) Introducer device for improved imaging
AU2013215446B2 (en) Fiducial placement system and splayed stylet
US20080139925A1 (en) MRI detectable obturator
CA2584645A1 (en) Fibrous marker formed of synthetic polymer strands

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION